(new: share price reversal, price assessment, analysts' comments)
FRANKFURT (dpa-AFX) – After a strong start following Thursday's quarterly report, shares of Siemens Healthineers have come under significant pressure. The strong euro and tariffs are weighing on the medical technology group. Analysts had mixed reactions to the figures. Overall, the report was deemed unconvincing, according to early morning trading commentary.
By early afternoon, the stock had recorded losses of 2.6 percent to €41.68, placing it among the laggards in the moderately weaker DAX. Technically, Healthineers still finds support around the €41 mark, a level where shares stabilized in both April and November.
Barclays noted that the company had a strong start to the fiscal year in its core business. In contrast, Jefferies analysts wrote that the start to the year had been sluggish. According to RBC analysts, robust performance in imaging technology and margins in precision medicine are being held back by a weaker diagnostics segment./ajx/jha/
-----------------------
dpa-AFX Broker – the trader news from dpa-AFX
-----------------------
